Souhaitez-vous accéder aux communiqués récents ?

Créez un compte lecteur dès aujourd’hui afin de suivre les secteurs et les entreprises qui vous intéressent, et configurer votre tableau de bord.

Se Connecter À Un Compte Lecteur Créer Un Compte Lecteur

13 avr. 2026 09h00 HE | Source: Portnoy Law

AVITA Medical, Inc. Investigated by the Portnoy Law Firm

LOS ANGELES, April 13, 2026 (GLOBE NEWSWIRE) -- The Portnoy Law Firm advises AVITA Medical, Inc., (“AVITA" or the "Company") (NASDAQ:RCEL) investors that the firm has initiated an investigation into...
08 janv. 2026 17h00 HE | Source: Bragar Eagel & Squire

Bragar Eagel & Squire, P.C. Encourages Soleno, Avita, and Coty Investors to Contact the Firm Regarding Ongoing Investigations

NEW YORK, Jan. 08, 2026 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, is investigating potential claims against Soleno Therapeutics, Inc....
03 déc. 2025 16h51 HE | Source: Bragar Eagel & Squire

Bragar Eagel & Squire, P.C. Encourages Agilon, Soleno, Avita, and Coty Investors to Contact the Firm Regarding Ongoing Investigations

NEW YORK, Dec. 03, 2025 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, is investigating potential claims against Agilon Health, Inc....
18 nov. 2025 17h22 HE | Source: Bragar Eagel & Squire

Bragar Eagel & Squire, P.C. Encourages Agilon, Soleno, Avita, and Coty Investors to Contact the Firm Regarding Ongoing Investigations

NEW YORK, Nov. 18, 2025 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, is investigating potential claims against Agilon Health, Inc....
10 nov. 2025 17h22 HE | Source: Bragar Eagel & Squire

Bragar Eagel & Squire, P.C. Is Investigating Agilon, Soleno, Avita, and Coty and Encourages Investors to Contact the Firm

NEW YORK, Nov. 10, 2025 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, is investigating potential claims against Agilon Health, Inc....
16 oct. 2025 17h43 HE | Source: Bragar Eagel & Squire

AVITA MEDICAL INVESTIGATION: Bragar Eagel & Squire, P.C. Reminds AVITA Medical Investors to Contact the Firm Regarding the Ongoing Investigation on Behalf of Stockholders

Avita allegedly revealed unpaid claim backlogs for Recell procedures, causing provider uncertainty and a 21% stock drop on August 8, 2025.
09 oct. 2025 12h49 HE | Source: Bragar Eagel & Squire

AVITA REMINDER: Bragar Eagel & Squire, P.C. Reminds AVITA Medical Investors to Contact the Firm Regarding the Ongoing Investigation on Behalf of Stockholders

Avita revealed a six-month backlog of unpaid Recell claims due to CMS pricing delays, hurting demand and driving shares down 21% to $4.25 on August 8, 2025
03 oct. 2025 07h45 HE | Source: Bragar Eagel & Squire

AVITA (RCEL) INVESTIGATION ALERT: Bragar Eagel & Squire, P.C. Continues Investigation into AVITA Medical, Inc. and Encourages Investors to Contact the Firm

Avita revealed CMS pricing delays caused a 6-month backlog in unpaid Recell claims, hurting demand; shares fell 21% to $4.25 on Aug 8, 2025.
25 sept. 2025 17h24 HE | Source: Bragar Eagel & Squire

AVITA INVESTIGATION ALERT: Bragar Eagel & Squire, P.C. is Investigating AVITA Medical, Inc. on Behalf of Avita Stockholders and Encourages Investors to Contact the Firm

Avita revealed a six-month backlog of unpaid Recell claims, hurting demand. Shares fell $1.13, or 21%, from $5.38 on Aug 7 to $4.25 on Aug 8, 2025.
15 sept. 2025 17h45 HE | Source: Bragar Eagel & Squire

AVITA ALERT: Bragar Eagel & Squire, P.C. is Investigating AVITA Medical, Inc. on Behalf of Avita Stockholders and Encourages Investors to Contact the Firm

Avita stock dropped 21% after Q2 2025 results revealed CMS pricing delays caused a six-month backlog of unpaid Recell claims.

Page suivante